Companies ›Healthcare ›STAA.JK

STAA.JK — IDX (Jakarta) Diversified Medical Equipment & Supplies

Sumber Tani Agung Resources Tbk PT

$1 230,00

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

4,47 %

Op margin

24,5 %

ROE

24,8 %

Net margin

16,6 %

Debt / equity

0,28

Beta

—

52w range

—

Volume

1,5k

Day range

$28,92–$29,78

Prev close

$29,08

Open

$29,08

Next earnings

2026-10-28

Ex-dividend

—

TR 1Y

—

About

Sumber Tani Agung Resources Tbk PT is an Indonesian company engaged in the fishing and farming industry, primarily generating revenue through the production and sale of food products.

Business. Sumber Tani Agung Resources Tbk PT (STAA.JK) is an Indonesian company engaged in the fishing and farming industry within the broader food and beverages sector. The firm operates primarily through the sale of food products. It is headquartered in Indonesia and is listed on the Indonesia Stock Exchange (IDX). Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification99 %

SectorHealth Care

Industry groupDiversified Medical Equipment & Supplies

Generated · model-assisted

Sell-side consensus

HOLD11 analysts

2 buy9 hold0 sell

Avg 12m price target21,11

Analyst recommendations

11 analysts · consensus Hold

Buy2

Hold9

Sell0

12-month price target

21,11

Consensus of sell-side coverage.

Upcoming events

EarningsQ3 2026 earnings (expected)2026-10-28 · estimated

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts→

Hold

11 analysts · indicative

Ownership→

BlackRock Institutional Trust Company, N.A.

largest disclosed fund holder

Profitability→

24,8 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning STAA.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to STAA.JK. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Company
EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Sumber Tani Agung Resources Tbk PT (STAA.JK) is an Indonesian company engaged in the fishing and farming industry within the broader food and beverages sector. The firm operates primarily through the sale of food products. It is headquartered in Indonesia and is listed on the Indonesia Stock Exchange (IDX). Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification99 %

SectorHealth Care

Industry groupDiversified Medical Equipment & Supplies

AI synthesis

GENERATED

Sumber Tani Agung Resources Tbk PT maintains a strong liquidity position, with a current ratio of 3.18, indicating the company can cover its short-term liabilities more than three times over. The company's liquidity is supported by cash and equivalents of IDR 397.42 billion, although its net cash position is negative after subtracting total debt. The debt-to-equity ratio of 0.28 suggests a conservative capital structure, with equity significantly outpacing debt.

In terms of profitability, the company's return on equity (ROE) of 24.84% and return on assets (ROA) of 16.8% are strong indicators of efficient capital use and asset management. These metrics suggest the company is generating substantial returns relative to its equity and total assets, which is favorable compared to the industry median for food and beverage producers.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This concentration may expose the company to higher operational and market risks if demand in its primary market fluctuates.

Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant revenue growth or decline projected in the next fiscal year. Historical revenue trends show consistent performance, with no sharp fluctuations reported in the most recent financial period.

The company faces moderate liquidity risk due to its negative net cash position, but the risk of dilution is low, as there is no indication of imminent share issuance or dilutive events. The company's capital expenditures of IDR 453.52 billion in the most recent period suggest ongoing investment in operations, which may support future growth.

No recent filings or transcripts have been disclosed that would indicate significant changes in the company's operations or strategy. The company's financial statements remain the primary source of information for assessing its performance and outlook.

Key takeaways

Sumber Tani Agung Resources Tbk PT has a strong liquidity position with a current ratio of 3.18.
The company's ROE of 24.84% and ROA of 16.8% indicate efficient capital and asset utilization.
The company's revenue is concentrated in a single business segment, which may increase operational risk.
The company's capital expenditures suggest ongoing investment in operations.
The risk of dilution is low, and the company's debt-to-equity ratio is conservative at 0.28.
No recent events have been disclosed that would significantly impact the company's operations or strategy.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

$1 230,00

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$6.47T

Net cashⓘ

-$1.39T

Current ratioⓘ

3.2

Debt / equityⓘ

0.3

ROAⓘ

16.8%

ROEⓘ

24.8%

Cash conversionⓘ

102.0%

CapEx / revenueⓘ

-4.7%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Ophthalmic Delivery Systems—

low · business_description · 2026-07-03

Ophthalmic Implants & Lenses—

low · business_description · 2026-07-03

Business relationships

Business relationships14 disclosed relationships · 1 type · extracted from filings & disclosures

Subsidiaries14

EX21:0e98cc0b1589EX21:0e98cc0b1589Subsidiarie97%Source ↗

EX21:0ffbcda795faEX21:0ffbcda795faSubsidiarie97%Source ↗

EX21:10ee4f7ea808EX21:10ee4f7ea808Subsidiarie97%

EX21:140bedbf9c3fEX21:140bedbf9c3fSubsidiarie97%Source ↗

EX21:33699b5f26ccEX21:33699b5f26ccSubsidiarie97%

EX21:38245b8cf4f7EX21:38245b8cf4f7Subsidiarie97%

EX21:470ddde1f4b4EX21:470ddde1f4b4Subsidiarie97%

EX21:50c0152c2952EX21:50c0152c2952Subsidiarie97%Source ↗

EX21:59ae856cd788EX21:59ae856cd788Subsidiarie97%Source ↗

EX21:7cdf553b15efEX21:7cdf553b15efSubsidiarie97%

EX21:8708cc752fb5EX21:8708cc752fb5Subsidiarie97%Source ↗

EX21:adb23315cbd2EX21:adb23315cbd2Subsidiarie97%

EX21:b579880414bcEX21:b579880414bcSubsidiarie97%

EX21:fb54e9062429EX21:fb54e9062429Subsidiarie97%Source ↗

Supply chain

— missing data

Peer comparison

Peer comparison8 peers · vs STAA · multiples and returns

ABT—

Abbott Laboratories

$107,13

187,2B USD

P/E

26,3x

— vs self

Div yield

2,4 %

— vs self

ROE

12,5 %

+35,9 vs self

MDT—

Medtronic PLC

$86,19

110,3B USD

P/E

21,4x

— vs self

Div yield

3,4 %

— vs self

ROE

9,7 %

+33,1 vs self

MDLN—

MEDLINE INC.

$40,47

53,2B USD

P/E

202,6x

— vs self

Div yield

—

— vs self

ROE

—

— vs self

SYK—

Stryker Corp

$341,20

131,8B USD

P/E

38,0x

— vs self

Div yield

—

— vs self

ROE

13,5 %

+36,9 vs self

BDX—

Becton Dickinson And Co

$170,21

48,4B USD

P/E

25,6x

— vs self

Div yield

2,8 %

— vs self

ROE

7,0 %

+30,3 vs self

HSIC—

Henry Schein Inc

$88,21

10,1B USD

P/E

80,5x

— vs self

Div yield

—

— vs self

ROE

3,0 %

+26,3 vs self

BAX—

Baxter International Inc

$28,10

14,5B USD

P/E

—

— vs self

Div yield

2,3 %

— vs self

ROE

-15,4 %

+7,9 vs self

SOLV—

SOLVENTUM CORPORATION

$76,83

13,3B USD

P/E

8,6x

— vs self

Div yield

—

— vs self

ROE

30,8 %

+54,2 vs self

Market position

Stress test

— missing data

Predictor forecast

Next quarternear-term

Earnings · next quarterconf 45 %

EPS

Consensus EPS

0,03

Predicted surprise

+0,00

Beat probability

45 %

Analysts

Other metrics

Revenue

—

no estimate

Segment revenue

—

no estimate

Margin

—

no estimate

Segment margin

—

no estimate

as of 2026-05-24 · Earnings Surprise V1

Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.

Probabilistic model output — not investment advice. · generated 2026-08-04

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

Low$16,00

Mean$21,11

Median$22,00

High$27,00

Spot$1 230,00

−98.3 %implied to mean12-month sell-side price targets · ▲ spot

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin24,5 %Above P75

Net Margin16,6 %Above P75

ROE24,8 %Above P75

Capex / Rev-4,7 %Bottom quartile

D/E0,28Above median

Cash Conv1,02Above median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

Derivative transactions

Net acquired 197 745 sh19 exercises · 17 grants10 insiders

SILVERMAN LOUDirector · Restricted Stock Units → Common StockAcquired 6 182grant · 2026-06-18
Wang Christopher Min FangDirector · Common Stock Option → Common Stock, par value $0.01 per shareAcquired 11 145 @ $29,12grant · 2026-06-18
LeBuhn Richard T.Director · OPTION TO PURCHASE COMMON STOCK → COMMON STOCKAcquired 11 145 @ $29,12grant · 2026-06-18
Bradsher Neal CDirector, 10% owner · OPTION TO PURCHASE COMMON STOCK → COMMON STOCKAcquired 11 145 @ $29,12grant · 2026-06-18
Butcher Arthur CDirector · Restricted Stock Units → Common StockDisposed 5 341exercise · 2026-06-18
Butcher Arthur CDirector · Common Stock Options → Common StockAcquired 4 458 @ $29,12grant · 2026-06-18
Butcher Arthur CDirector · Restricted Stock Units → Common StockAcquired 3 709grant · 2026-06-18
Zhou Lilian YanshengDirector · Restricted Stock Units → Common StockAcquired 3 091grant · 2026-06-18
Zhou Lilian YanshengDirector · Common Stock Options → Common StockAcquired 5 572 @ $29,12grant · 2026-06-18
SILVERMAN LOUDirector · Restricted Stock Units → Common StockDisposed 10 683exercise · 2026-06-18
Jiang WeiDirector · Restricted Stock Units → Common StockDisposed 10 683exercise · 2026-06-18
Jiang WeiDirector · Restricted Stock Units → Common StockAcquired 6 182grant · 2026-06-18
ANDREWS DEBORAH JInterim Co-CEO and CFO · Performance Stock Units → Common StockAcquired 5 233exercise · 2026-05-15
ANDREWS DEBORAH JInterim Co-CEO and CFO · Performance Stock Units → Common StockAcquired 10 466exercise · 2026-05-15
Foust WarrenInterim Co-CEO and Pres. & COO · Performance Stock Units → Common StockAcquired 14 662exercise · 2026-05-15
Foust WarrenInterim Co-CEO and Pres. & COO · Performance Stock Units → Common StockAcquired 3 666exercise · 2026-05-15
Foust WarrenInterim Co-CEO and Pres. & COO · Performance Stock Units → Common StockAcquired 7 331exercise · 2026-05-15
Michna MagdaChief Development Officer · Performance Stock Units → Common StockAcquired 5 499exercise · 2026-05-15
Michna MagdaChief Development Officer · Performance Stock Units → Common StockAcquired 1 100exercise · 2026-05-15
Michna MagdaChief Development Officer · Performance Stock Units → Common StockAcquired 10 997exercise · 2026-05-15
Michna MagdaChief Development Officer · Performance Stock Units → Common StockAcquired 2 199exercise · 2026-05-15
Foust WarrenInterim Co-CEO and Pres. & COO · Restricted Stock Units → Common StockDisposed 19 550exercise · 2026-03-14
Foust WarrenInterim Co-CEO and Pres. & COO · Restricted Stock Units → Common StockDisposed 9 775exercise · 2026-03-14
Michna MagdaChief Development Officer · Restricted Stock Units → Common StockDisposed 2 932exercise · 2026-03-14
Michna MagdaChief Development Officer · Restricted Stock Units → Common StockDisposed 14 663exercise · 2026-03-14

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

Sumber Tani Agung Resources Tbk PT Market data — financials · 2026-05-29

Ownership & reference

Top holders

BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,01 %$357M
Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$15M
Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$20M
Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,00 %$5M
Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$28M
Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$98M
JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$2M
State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$34M
Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$19M
Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$8M
Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$4M
Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$7M
Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$4M
UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$3M
AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$1M
Invesco QQQ TrustFunds · as of 2026-03-310,00 %$3M
AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$2M
American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$1M
Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$1M
T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M
JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

Insider activity

Net buying6 buys · 0 sellsnet $12,3M8 insiders · last 365d

Butcher Arthur CDirector · Common StockOther 5 341 · 2026-06-18
Jiang WeiDirector · Common StockOther 10 683 · 2026-06-18
SILVERMAN LOUDirector · Common StockOther 10 683 · 2026-06-18
Zhou Lilian YanshengDirector · Common StockOther 3 530 @ $28,29$100K · 2026-06-12
Foust WarrenInterim Co-CEO and Pres. & COO · Common StockOther 14 662 · 2026-05-15
Michna MagdaChief Development Officer · Common StockOther 2 199 · 2026-05-15
ANDREWS DEBORAH JInterim Co-CEO and CFO · Common StockOther 10 466 · 2026-05-15
ANDREWS DEBORAH JInterim Co-CEO and CFO · Common StockOther 3 755 @ $32,07$120K · 2026-05-15
ANDREWS DEBORAH JInterim Co-CEO and CFO · Common StockOther 5 233 · 2026-05-15
ANDREWS DEBORAH JInterim Co-CEO and CFO · Common StockOther 1 877 @ $32,07$60K · 2026-05-15
Foust WarrenInterim Co-CEO and Pres. & COO · Common StockOther 7 460 @ $32,07$239K · 2026-05-15
Foust WarrenInterim Co-CEO and Pres. & COO · Common StockOther 7 331 · 2026-05-15
Foust WarrenInterim Co-CEO and Pres. & COO · Common StockOther 3 730 @ $32,07$120K · 2026-05-15
Foust WarrenInterim Co-CEO and Pres. & COO · Common StockOther 3 666 · 2026-05-15
Foust WarrenInterim Co-CEO and Pres. & COO · Common StockOther 1 865 @ $32,07$60K · 2026-05-15
Michna MagdaChief Development Officer · Common StockOther 10 997 · 2026-05-15
Michna MagdaChief Development Officer · Common StockOther 5 595 @ $32,07$179K · 2026-05-15
Michna MagdaChief Development Officer · Common StockOther 5 499 · 2026-05-15
Michna MagdaChief Development Officer · Common StockOther 2 431 @ $32,07$78K · 2026-05-15
Michna MagdaChief Development Officer · Common StockOther 1 118 @ $32,07$36K · 2026-05-15
Michna MagdaChief Development Officer · Common StockOther 1 100 · 2026-05-15
Michna MagdaChief Development Officer · Common StockOther 559 @ $32,07$18K · 2026-05-15
Michna MagdaChief Development Officer · Common StockOther 1 680 @ $26,69$45K · 2026-05-08
Foust WarrenInterim Co-CEO and Pres. & COO · Common StockOther 3 448 @ $26,69$92K · 2026-05-08
Foust WarrenInterim Co-CEO and Pres. & COO · Common StockOther 19 550 · 2026-03-14

Short positioning

5.1Mshares short-3.5% vs prior

7.67days to cover

37.0%short of daily vol

22.5Kfails-to-deliver

as of 2026-07-15 · short-interest report (free)

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

STAA.JKCanonical

IDX (Jakarta) · USD

Intel & risk

PredictorBeat prob45 %Surprise+0,00Full forecast →

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Relationship graph

This companySectorSubsidiaries

Evidence & claims

From filings & derived data

Total assets (YoY) (2026-01-02 vs 2024-12-27): -11.4%Derived (calculated)
Net margin (FY 2026-01-02): -33.6%Derived (calculated)
Gross margin (FY 2026-01-02): 76.2%Derived (calculated)
Return on equity (FY 2026-01-02): -23.4%Derived (calculated)
Return on assets (FY 2026-01-02): -17.8%Derived (calculated)
Current ratio (FY 2026-01-02): 4.55xDerived (calculated)
Debt-to-equity (FY 2026-01-02): 0.31xDerived (calculated)
Capex (YoY) (2026-01-02 vs 2024-12-27): -75.1%Derived (calculated)
Cash & equivalents (YoY) (2026-01-02 vs 2024-12-27): 6.2%Derived (calculated)
Cost of revenue (YoY) (2026-01-02 vs 2024-12-27): -23.3%Derived (calculated)
EPS (basic) (YoY) (2026-01-02 vs 2024-12-27): -295.1%Derived (calculated)
EPS (diluted) (YoY) (2026-01-02 vs 2024-12-27): -295.1%Derived (calculated)
Gross profit (YoY) (2026-01-02 vs 2024-12-27): -23.9%Derived (calculated)
Net income (YoY) (2026-01-02 vs 2024-12-27): -298.1%Derived (calculated)
Operating cash flow (YoY) (2026-01-02 vs 2024-12-27): -317.7%Derived (calculated)
Operating income (YoY) (2026-01-02 vs 2024-12-27): -627.2%Derived (calculated)
R&D expense (YoY) (2026-01-02 vs 2024-12-27): -11.6%Derived (calculated)
Revenue (YoY) (2026-01-02 vs 2024-12-27): -23.7%Derived (calculated)
Shareholders' equity (YoY) (2026-01-02 vs 2024-12-27): -13.4%Derived (calculated)
Total liabilities (YoY) (2026-01-02 vs 2024-12-27): -4.2%Derived (calculated)
Revenue (annual): USD 239.44MSEC XBRL filing
Net income (annual): USD -80.45MSEC XBRL filing
Pre-tax income (annual): USD -82.26MSEC XBRL filing
EPS (diluted) (annual): USD-PER-SHARES -2SEC XBRL filing

Showing 24 of 60 surfaced claims.

Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

The Thread

Everything we know, in order

2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date

2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)

2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated

2026-06-18 00:00 UTCINSIDER16 insider transactions — 2026-06 12 derivative

2026-06-18INSIDERButcher Arthur C transacted 5.3k sh — Director

2026-06-18INSIDERJiang Wei transacted 10.7k sh — Director

2026-06-18INSIDERSILVERMAN LOU transacted 10.7k sh — Director

2026-06-18INSIDERBradsher Neal C acquired 11.1k sh OPTION TO PURCHASE COMMON STOCK — Director, 10% owner

2026-06-18INSIDERJiang Wei acquired 6.2k sh Restricted Stock Units — Director

2026-06-18INSIDERJiang Wei disposed of 10.7k sh Restricted Stock Units — Director

2026-06-18INSIDERSILVERMAN LOU acquired 6.2k sh Restricted Stock Units — Director

2026-06-18INSIDERSILVERMAN LOU disposed of 10.7k sh Restricted Stock Units — Director

2026-06-18INSIDERZhou Lilian Yansheng acquired 5.6k sh Common Stock Options — Director

2026-06-18INSIDERZhou Lilian Yansheng acquired 3.1k sh Restricted Stock Units — Director

2026-06-18INSIDERButcher Arthur C acquired 3.7k sh Restricted Stock Units — Director

2026-06-18INSIDERButcher Arthur C acquired 4.5k sh Common Stock Options — Director

2026-06-18INSIDERButcher Arthur C disposed of 5.3k sh Restricted Stock Units — Director

2026-06-18INSIDERLeBuhn Richard T. acquired 11.1k sh OPTION TO PURCHASE COMMON STOCK — Director

2026-06-18INSIDERWang Christopher Min Fang acquired 11.1k sh Common Stock Option — Director

2026-06-12INSIDERZhou Lilian Yansheng transacted 3.5k sh — Director ~$100k

2026-06-09FILING8-K filing →

2026-05-15 00:00 UTCINSIDER29 insider transactions — 2026-05 · net sell $1.0M 9 derivative

2026-05-15INSIDERFoust Warren transacted 14.7k sh — Interim Co-CEO and Pres. & COO

2026-05-15INSIDERMichna Magda transacted 2.2k sh — Chief Development Officer

2026-05-15INSIDERANDREWS DEBORAH J transacted 10.5k sh — Interim Co-CEO and CFO

2026-05-15INSIDERANDREWS DEBORAH J transacted 3.8k sh — Interim Co-CEO and CFO ~$120k

2026-05-15INSIDERANDREWS DEBORAH J transacted 5.2k sh — Interim Co-CEO and CFO

2026-05-15INSIDERANDREWS DEBORAH J transacted 1.9k sh — Interim Co-CEO and CFO ~$60k

2026-05-15INSIDERFoust Warren transacted 7.5k sh — Interim Co-CEO and Pres. & COO ~$239k

2026-05-15INSIDERFoust Warren transacted 7.3k sh — Interim Co-CEO and Pres. & COO

2026-05-15INSIDERFoust Warren transacted 3.7k sh — Interim Co-CEO and Pres. & COO ~$120k

2026-05-15INSIDERFoust Warren transacted 3.7k sh — Interim Co-CEO and Pres. & COO

2026-05-15INSIDERFoust Warren transacted 1.9k sh — Interim Co-CEO and Pres. & COO ~$60k

2026-05-15INSIDERMichna Magda transacted 11.0k sh — Chief Development Officer

2026-05-15INSIDERMichna Magda transacted 5.6k sh — Chief Development Officer ~$179k

2026-05-15INSIDERMichna Magda transacted 5.5k sh — Chief Development Officer

2026-05-15INSIDERMichna Magda transacted 2.4k sh — Chief Development Officer ~$78k

2026-05-15INSIDERMichna Magda transacted 1.1k sh — Chief Development Officer ~$36k

2026-05-15INSIDERMichna Magda transacted 1.1k sh — Chief Development Officer

Showing the 40 most recent of 61 entries.

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

Analyst recommendations

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Derivative transactions

Actions

Ask Handelsavisen

Ownership & reference

Top holders

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread